A case of pityriasis lichenoides et varioliformis acuta developed after first dose of <scp>Oxford–AstraZeneca COVID</scp> ‐19 vaccine

MLA

F. Filippi, et al. “A Case of Pityriasis Lichenoides et Varioliformis Acuta Developed after First Dose of Oxford–AstraZeneca COVID ‐19 Vaccine.” Journal of the European Academy of Dermatology and Venereology, vol. 36, June 2022. EBSCOhost, https://doi.org/10.1111/jdv.18269.

APA

F. Filippi, C. Baraldi, P.L. Zinzani, B. Casadei, & A. Pileri. (2022). A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford–AstraZeneca COVID ‐19 vaccine. Journal of the European Academy of Dermatology and Venereology, 36. https://doi.org/10.1111/jdv.18269

Chicago

F. Filippi, C. Baraldi, P.L. Zinzani, B. Casadei, and A. Pileri. 2022. “A Case of Pityriasis Lichenoides et Varioliformis Acuta Developed after First Dose of Oxford–AstraZeneca COVID ‐19 Vaccine.” Journal of the European Academy of Dermatology and Venereology 36 (June). doi:10.1111/jdv.18269.